Marshall Wace
TWST icon

Marshall Wace’s Twist Bioscience TWST Stock Holding History

Marshall Wace’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.8M Buy
+396,912
New +$25.8M 0.03% 447
2025
Q4 		– Sell
-44,066
Closed -$1.24M – 3494
2025
Q3 		$1.24M Buy
+44,066
New +$1.33M ﹤0.01% 1853
2025
Q2 		– Sell
-318,188
Closed -$12.5M – 3191
2025
Q1 		$12.5M Sell
318,188
-527,919
-62% -$23.8M 0.02% 684
2024
Q4 		$39.3M Buy
846,107
+840,828
+15,928% +$38M 0.05% 337
2024
Q3 		$239K Buy
+5,279
New +$251K ﹤0.01% 2239
2023
Q4 		– Sell
-220,572
Closed -$4.47M – 2623
2023
Q3 		$4.47M Sell
220,572
-680,892
-76% -$15M 0.01% 916
2023
Q2 		$18.4M Buy
901,464
+541,327
+150% +$8.11M 0.04% 508
2023
Q1 		$5.43M Sell
360,137
-418,065
-54% -$9.24M 0.01% 959
2022
Q4 		$18.5M Sell
778,202
-417,195
-35% -$12.1M 0.04% 481
2022
Q3 		$42.1M Sell
1,195,397
-864,193
-42% -$36.7M 0.09% 238
2022
Q2 		$72M Buy
2,059,590
+362,695
+21% +$12.8M 0.15% 140
2022
Q1 		$83.8M Buy
1,696,895
+443,347
+35% +$24.6M 0.16% 136
2021
Q4 		$97M Buy
1,253,548
+305,058
+32% +$31.3M 0.18% 104
2021
Q3 		$101M Sell
948,490
-63,363
-6% -$7.26M 0.42% 27
2021
Q2 		$135M Buy
1,011,853
+157,341
+18% +$18.3M 0.61% 16
2021
Q1 		$106M Buy
854,512
+326,930
+62% +$49.6M 0.49% 29
2020
Q4 		$74.5M Sell
527,582
-59,372
-10% -$6.59M 0.4% 46
2020
Q3 		$44.6M Buy
586,954
+514,071
+705% +$32M 0.29% 78
2020
Q2 		$3.3M Buy
+72,883
New +$2.62M 0.02% 607

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Marshall Wace's TWST Position: Q2 2026 in Review

Marshall Wace opened a new position in Twist Bioscience (TWST) in Q2 2026: 396,912 shares worth $40.8M. The stake represents 0.03% of the portfolio and ranks #447 among its holdings. This is a return to the name: Marshall Wace previously reported a position in TWST as recently as Q3 2025.

Marshall Wace first reported a position in TWST in Q2 2020 and has held it in 19 quarters since. The position peaked at $135M in Q2 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Marshall Wace held 396,912 shares of Twist Bioscience worth $40.8M as of Q2 2026.
  • Twist Bioscience was a new Marshall Wace position in Q2 2026.
  • Twist Bioscience made up 0.03% of Marshall Wace's portfolio in Q2 2026, its #447 holding.
  • Marshall Wace first reported a position in Twist Bioscience in Q2 2020 and has held it in 19 quarters since.
  • Marshall Wace's Twist Bioscience position peaked at $135M in Q2 2021.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.